| Aktie | Ticker | 2025/Q3 | 2025/Q1 | ||
|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 630.889.037 $ | +239.153.236 $ | 395.095.066 $ | +395.095.066 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 248.302.941 $ | +96.473.131 $ | 151.829.810 $ | +151.829.810 $ |
| INSMED Inc | INSM | 163.049.850 $ | +138.771.397 $ | 24.278.453 $ | +24.278.453 $ |
| ELI LILLY & Co | LLY | 21.898.100 $ | -93.635.972 $ | 115.534.072 $ | +115.534.072 $ |
| ARGENX SE | ARGX | 57.759.061 $ | +51.064.476 $ | 6.694.585 $ | +6.694.585 $ |
| SOLENO THERAPEUTICS INC | SLNO | 45.439.098 $ | -7.103.303 $ | 52.542.401 $ | +52.542.401 $ |
| CITIGROUP INC | C | 24.751.354 $ | +24.751.354 $ | ||
| BOSTON SCIENTIFIC CORP | BSX | 17.885.816 $ | +4.801.680 $ | 13.084.136 $ | +13.084.136 $ |
| QUEST DIAGNOSTICS INC | DGX | 15.573.626 $ | +5.977.110 $ | 9.596.516 $ | +9.596.516 $ |
| ASTRAZENECA PLC | AZN | 14.634.493 $ | +614.221 $ | 14.020.272 $ | +14.020.272 $ |
| IONIS PHARMACEUTICALS INC | IONS | 3.936.714 $ | +3.936.714 $ | ||
| AbbVie Inc. | ABBV | 3.357.330 $ | +3.357.330 $ | ||
| NEKTAR THERAPEUTICS | NKTR | 3.300.143 $ | +3.300.143 $ | ||
| Centessa Pharmaceuticals plc | CNTA | 3.232.307 $ | +2.725.757 $ | 506.550 $ | +506.550 $ |
| Ascendis Pharma A/S | ASND | 2.433.434 $ | +1.273.836 $ | 1.159.598 $ | +1.159.598 $ |
| UNITED THERAPEUTICS Corp | UTHR | 2.096.050 $ | +554.700 $ | 1.541.350 $ | +1.541.350 $ |
| INTUITIVE SURGICAL INC | ISRG | 1.733.445 $ | +1.733.445 $ | ||
| NEUROCRINE BIOSCIENCES INC | NBIX | 1.625.820 $ | +1.625.820 $ | ||
| IREN Ltd | IREN | 1.558.076 $ | +1.558.076 $ | ||
| Mereo BioPharma Group plc | MREO | 979.244 $ | +31.186 $ | 948.058 $ | +948.058 $ |
| aTYR PHARMA INC | ATYR | 701.400 $ | +701.400 $ | ||
| 630.889.037 $ | +239.153.236 $ | 395.095.066 $ | +395.095.066 $ | ||
Erweiterte Einstellungen
×